Literature DB >> 33623001

Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors.

Avinash K Persaud1, Sreenath Nair1, Md Fazlur Rahman1, Radhika Raj1, Brenna Weadick1, Debasis Nayak1, Craig McElroy1, Muruganandan Shanmugam1, Sue Knoblaugh2, Xiaolin Cheng3, Rajgopal Govindarajan4,5.   

Abstract

Mutations in human equilibrative nucleoside transporter 3 (ENT3) encoded by SLC29A3 results in anemia and erythroid hypoplasia, suggesting that ENT3 may regulate erythropoiesis. Here, we demonstrate that lysosomal ENT3 transport of taurine-conjugated bile acids (TBA) facilitates TBA chemical chaperone function and alleviates endoplasmic reticulum (ER) stress in expanding mouse hematopoietic stem and progenitor cells (HSPCs). Slc29a3-/- HSPCs accumulate less TBA despite elevated levels of TBA in Slc29a3-/- mouse plasma and have elevated basal ER stress, reactive oxygen species (ROS), and radiation-induced apoptosis. Reintroduction of ENT3 allows for increased accumulation of TBA into HSPCs, which results in TBA-mediated alleviation of ER stress and erythroid apoptosis. Transplanting TBA-preconditioned HSPCs expressing ENT3 into Slc29a3-/- mice increase bone marrow repopulation capacity and erythroid pool size and prevent early mortalities. Together, these findings suggest a putative role for a facilitative lysosomal transporter in the bile acid regulation of ER stress in mouse HSPCs which may have implications in erythroid biology, the treatment of anemia observed in ENT3-mutated human genetic disorders, and nucleoside analog drug therapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33623001     DOI: 10.1038/s41467-021-21451-6

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  40 in total

1.  SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.

Authors:  J de Jesus; Z Imane; V Senée; S Romero; P-J Guillausseau; A Balafrej; C Julier
Journal:  Diabetes Metab       Date:  2013-04-23       Impact factor: 6.041

2.  Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.

Authors:  Philippe M Campeau; James T Lu; Gautam Sule; Ming-Ming Jiang; Yangjin Bae; Simran Madan; Wolfgang Högler; Nicholas J Shaw; Steven Mumm; Richard A Gibbs; Michael P Whyte; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-08-08       Impact factor: 6.150

3.  Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.

Authors:  Md Fazlur Rahman; Candice Askwith; Rajgopal Govindarajan
Journal:  J Biol Chem       Date:  2017-07-20       Impact factor: 5.157

Review 4.  Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins.

Authors:  J D Young; S Y M Yao; L Sun; C E Cass; S A Baldwin
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

5.  Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.

Authors:  Isabelle Melki; Karen Lambot; Laurence Jonard; Vincent Couloigner; Pierre Quartier; Bénédicte Neven; Brigitte Bader-Meunier
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

6.  Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect.

Authors:  Deniz Çağdaş; Naz Sürücü; Çağman Tan; Başak Kayaoğlu; Rıza Köksal Özgül; Yeliz Z Akkaya-Ulum; Ayşe Tülay Aydınoğlu; Selin Aytaç; Fatma Gümrük; Burcu Balci-Hayta; Banu Balci-Peynircioğlu; Seza Özen; Mayda Gürsel; İlhan Tezcan
Journal:  Mol Immunol       Date:  2020-03-06       Impact factor: 4.407

7.  [H syndrome: First reported paediatric case in Latin America].

Authors:  Hugo Hernán Abarca Barriga; Milana Trubnykova; Victoria Polar Córdoba; Katherine Joyce Ramos Diaz; Nélida Aviles Alfaro
Journal:  Rev Chil Pediatr       Date:  2016-04-30

8.  The H syndrome is caused by mutations in the nucleoside transporter hENT3.

Authors:  Vered Molho-Pessach; Israela Lerer; Dvorah Abeliovich; Ziad Agha; Abdulasalam Abu Libdeh; Valentina Broshtilova; Orly Elpeleg; Abraham Zlotogorski
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025

9.  Lysosomal solute carrier transporters gain momentum in research.

Authors:  B Bissa; A M Beedle; R Govindarajan
Journal:  Clin Pharmacol Ther       Date:  2016-09-15       Impact factor: 6.875

10.  H syndrome: 5 new cases from the United States with novel features and responses to therapy.

Authors:  Jessica L Bloom; Clara Lin; Lisa Imundo; Stephen Guthery; Shelly Stepenaskie; Csaba Galambos; Amy Lowichik; John F Bohnsack
Journal:  Pediatr Rheumatol Online J       Date:  2017-10-17       Impact factor: 3.054

View more
  5 in total

Review 1.  Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective.

Authors:  Syed Saqib Ali; Ruchika Raj; Tejinder Kaur; Brenna Weadick; Debasis Nayak; Minnsung No; Jane Protos; Hannah Odom; Kajal Desai; Avinash K Persaud; Joanne Wang; Rajgopal Govindarajan
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

Review 2.  Hormetic endoplasmic reticulum stress in hematopoietic stem cells.

Authors:  Larry L Luchsinger
Journal:  Curr Opin Hematol       Date:  2021-11-01       Impact factor: 3.284

Review 3.  The Role of Nutrients in Maintaining Hematopoietic Stem Cells and Healthy Hematopoiesis for Life.

Authors:  Yuko Tadokoro; Atsushi Hirao
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

Review 4.  New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.

Authors:  Kathleen M Giacomini; Sook W Yee; Megan L Koleske; Ling Zou; Pär Matsson; Eugene C Chen; Deanna L Kroetz; Miles A Miller; Elnaz Gozalpour; Xiaoyan Chu
Journal:  Clin Pharmacol Ther       Date:  2022-05-20       Impact factor: 6.903

Review 5.  Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29).

Authors:  Marçal Pastor-Anglada; Aida Mata-Ventosa; Sandra Pérez-Torras
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.